骨科指南

订阅

MedSci主页 / 所有栏目 / 骨科指南

中国髋关节置换入路选择临床实践指南(2021年版)

2021-12-01 中华医学会骨科学分会关节外科学组 中华关节外科杂志(电子版)

全髋关节置换术人工关节置换术

全髋关节置换术(THA)在缓解终末期髋部相关疾病疼痛和恢复肢体功能方面发挥着重要作用,THA手术量呈持续高增长态势。然而国内外尚无关于THA入路选择的诊疗指南或专家共识。

中文标题：

中国髋关节置换入路选择临床实践指南(2021年版)

发布机构：

中华医学会骨科学分会关节外科学组

发布日期：

2021-12-01

简要介绍：

全髋关节置换术(THA)在缓解终末期髋部相关疾病疼痛和恢复肢体功能方面发挥着重要作用,THA手术量呈持续高增长态势。然而国内外尚无关于THA入路选择的诊疗指南或专家共识。因此制定基于循证医学证据的THA入路选择临床实践指南具有重要意义。指南制定由中华医学会骨科学分会关节外科学组和中华关节外科杂志(电子版)发起,设计与制订遵循《世界卫生组织指南制订手册》和"制订/修订<临床诊疗指南>的基本方法及程序",根据推荐意见分级的评估、制订及评价(GRADE)分级体系和国际实践指南报告标准(RIGHT)指南评价工具遴选出11个临床问题,最终形成11条循证医学推荐意见,旨在指导广大相关医务工作者针对手术入路选择的临床实践,共同为THA患者的良好预后提供规范性指引。 

下载附件：
点击下载

(因为版权问题，不支持下载)

评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1230346, encodeId=aad01230346bc, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8f76470966, createdName=ms4000001312136633, createdTime=Sun Jul 03 20:58:48 CST 2022, time=2022-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196602, encodeId=8df31196602d0, content=好用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201123/ec6818f0b3a34c76b9db53c38ef58f13/763f5e8fbc8a4bc1a486cfe5b4e09829.jpg, createdBy=43595437601, createdName=Yuxintong66 , createdTime=Wed Feb 23 22:58:56 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196471, encodeId=0b9011964e17d, content=指南很细很新，很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34f02649883, createdName=109034249, createdTime=Wed Feb 23 16:50:13 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195440, encodeId=1f661195440a9, content=很好，很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Sun Feb 20 21:22:38 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194940, encodeId=f753119494037, content=看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99114817120, createdName=504317425, createdTime=Fri Feb 18 23:38:46 CST 2022, time=2022-02-18, status=1, ipAttribution=)]
    2022-07-03 ms4000001312136633

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1230346, encodeId=aad01230346bc, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8f76470966, createdName=ms4000001312136633, createdTime=Sun Jul 03 20:58:48 CST 2022, time=2022-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196602, encodeId=8df31196602d0, content=好用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201123/ec6818f0b3a34c76b9db53c38ef58f13/763f5e8fbc8a4bc1a486cfe5b4e09829.jpg, createdBy=43595437601, createdName=Yuxintong66 , createdTime=Wed Feb 23 22:58:56 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196471, encodeId=0b9011964e17d, content=指南很细很新，很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34f02649883, createdName=109034249, createdTime=Wed Feb 23 16:50:13 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195440, encodeId=1f661195440a9, content=很好，很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Sun Feb 20 21:22:38 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194940, encodeId=f753119494037, content=看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99114817120, createdName=504317425, createdTime=Fri Feb 18 23:38:46 CST 2022, time=2022-02-18, status=1, ipAttribution=)]
    2022-02-23 Yuxintong66

    好用

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1230346, encodeId=aad01230346bc, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8f76470966, createdName=ms4000001312136633, createdTime=Sun Jul 03 20:58:48 CST 2022, time=2022-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196602, encodeId=8df31196602d0, content=好用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201123/ec6818f0b3a34c76b9db53c38ef58f13/763f5e8fbc8a4bc1a486cfe5b4e09829.jpg, createdBy=43595437601, createdName=Yuxintong66 , createdTime=Wed Feb 23 22:58:56 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196471, encodeId=0b9011964e17d, content=指南很细很新，很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34f02649883, createdName=109034249, createdTime=Wed Feb 23 16:50:13 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195440, encodeId=1f661195440a9, content=很好，很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Sun Feb 20 21:22:38 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194940, encodeId=f753119494037, content=看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99114817120, createdName=504317425, createdTime=Fri Feb 18 23:38:46 CST 2022, time=2022-02-18, status=1, ipAttribution=)]
    2022-02-23 109034249

    指南很细很新，很实用

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1230346, encodeId=aad01230346bc, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8f76470966, createdName=ms4000001312136633, createdTime=Sun Jul 03 20:58:48 CST 2022, time=2022-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196602, encodeId=8df31196602d0, content=好用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201123/ec6818f0b3a34c76b9db53c38ef58f13/763f5e8fbc8a4bc1a486cfe5b4e09829.jpg, createdBy=43595437601, createdName=Yuxintong66 , createdTime=Wed Feb 23 22:58:56 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196471, encodeId=0b9011964e17d, content=指南很细很新，很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34f02649883, createdName=109034249, createdTime=Wed Feb 23 16:50:13 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195440, encodeId=1f661195440a9, content=很好，很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Sun Feb 20 21:22:38 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194940, encodeId=f753119494037, content=看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99114817120, createdName=504317425, createdTime=Fri Feb 18 23:38:46 CST 2022, time=2022-02-18, status=1, ipAttribution=)]
    2022-02-20 ms3000000637975859

    很好，很实用

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1230346, encodeId=aad01230346bc, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8f76470966, createdName=ms4000001312136633, createdTime=Sun Jul 03 20:58:48 CST 2022, time=2022-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196602, encodeId=8df31196602d0, content=好用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201123/ec6818f0b3a34c76b9db53c38ef58f13/763f5e8fbc8a4bc1a486cfe5b4e09829.jpg, createdBy=43595437601, createdName=Yuxintong66 , createdTime=Wed Feb 23 22:58:56 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196471, encodeId=0b9011964e17d, content=指南很细很新，很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34f02649883, createdName=109034249, createdTime=Wed Feb 23 16:50:13 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195440, encodeId=1f661195440a9, content=很好，很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Sun Feb 20 21:22:38 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194940, encodeId=f753119494037, content=看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99114817120, createdName=504317425, createdTime=Fri Feb 18 23:38:46 CST 2022, time=2022-02-18, status=1, ipAttribution=)]
    2022-02-18 504317425

    看看

    0

相关指南

2019 ERAS建议：全髋关节置换术和全膝关节置换术围术期护理共识声明

促进术后恢复学会(ERAS,The Enhanced Recovery After Surgery Society) · 2019-10-30

围手术期抗风湿病药物使用管理最新指南

暂未更新 · 2017-12-30